作者：
Issei,Tomita [1]
;
Shinji,Kume [2]
;
Sho,Sugahara [1]
;
Norihisa,Osawa [1]
;
Kosuke,Yamahara [1]
;
Mako,Yasuda-Yamahara [1]
;
Naoko,Takeda [3]
;
Masami,Chin-Kanasaki [3]
;
Tatsuroh,Kaneko [4]
;
Eric,Mayoux [5]
;
Michael,Mark [5]
;
Motoko,Yanagita [6]
;
Hisakazu,Ogita [7]
;
Shin-Ichi,Araki [3]
;
Hiroshi,Maegawa [8]
作者单位：
Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan.
[1]
Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan. Electronic address: skume@belle.shiga-med.ac.jp.
[2]
Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan; Division of Blood Purification, Shiga University of Medical Science Hospital, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan.
[3]
Medicine Division, Nippon Boehringer Ingelheim Co., Ltd., 2-1-1 Osaki, Shinagawa-ku, Tokyo 141-6017, Japan.
[4]
CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, Biberach an der Riss 88397, Germany.
[5]
Department of Nephrology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan.
[6]
Division of Molecular Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan.
[7]
Department of Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192, Japan. Electronic address: maegawa@belle.shiga-med.ac.jp.
[8]
DOI
10.1016/j.cmet.2020.06.020
PMID
32726607
发布时间
2021-11-08
换一批
换一批
